antifungal-agents

Documents about antifungal-agents

• Synthesis of novel carboxylic and phosphonic acid corroles: Spectroscopic characterizations and antifungal properties#347831HAL (France)
• The sulfur-related metabolic status of during infection reveals cytosolic serine hydroxymethyltransferase as a promising antifungal target.#455670Repisalud
• Effect of Calcium Silicate-Based Root Canal Medicament After Retreatment#1141045ClinicalTrials.gov
• The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us#5634Europe PMC
• Anti bacterial activity and anti fungal activity screening of the 'kamutmut' plant against pathogens#259159Animo Repository
• Integrated Approach for the Discovery of Antifungal and Antibiofilm Agents From Cerrado Plants#448822HAL (France)
• Infecciones micóticas en odontoestomatología#641697Dipòsit Digital de la Universitat de Barcelona
• Pharmacokinetic Study in Patients Receiving Posaconazole Therapy in Taiwan#854907ClinicalTrials.gov
• Pharmacological advances in#389554PubMed
• Amphotericin B for Non-HIV Cryptococcal Meningitis Patients#897844ClinicalTrials.gov
• Antifungal susceptibility testing and genotyping characterization of Cryptococcus neoformans and gattii isolates from HIV-infected patients of Ribeirão Preto, São Paulo, brazil#345449Repositório Institucional da Universidade Federal de Sergipe
• Thiazolidinsone derivatives bearing sulfonamide group as potential antimicrobial agents: biological and in silico evaluation#612383IBISS
• The Metabolites Produced by Citrus reticulata-Derived Endophyte Aspergillus fumigatus as Potential Antifungal Agents Against Citrus Pathogens.#440949NCBI PubMed Central
• Interpretable Quantitative Structure-Activity Relationship (QSAR) for identification of potent antifungal activity agents towards Candida albicans ATCC 2091.#224809NCBI PubMed Central
• Bioactive Constituents of Piper crocatum Ruiz & Pav. and Piper betle Linn. as Antifungal and Antibiofilm Agents Against Candida albicans.#662773NCBI PubMed Central
• Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients#1009326ClinicalTrials.gov
• Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers#1280391ClinicalTrials.gov
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945#1407554ClinicalTrials.gov
• Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration#1150116ClinicalTrials.gov
• WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC data 2020–2021#470954WHO IRIS
• WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC data 2023#470965WHO IRIS
• The emerging pathogen Candida auris: host interactions and disease drivers#374488HAL (France)
• Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents#860061ClinicalTrials.gov
• Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients#1161450ClinicalTrials.gov
• Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease#1041402Repositorio Universidad del Desarrollo
• Antifungal activity of Co(II) and Cu(II) complexes containing 1,3-bis(benzotriazol-1-yl)-propan-2-ol on the growth and virulence traits of fluconazole-resistant Candida species: synthesis, DFT calculations, and biological activity#948021Repositorio de Universidad Autónoma de Chile.
• The future of fungal diagnostics: What's next in laboratory testing for invasive fungal infection?#780671Europe PMC
• Étude du mode d’action de rhamnolipides et de fengycines, antifongiques membranotropes naturels prometteurs, sur Botrytis cinerea et Sclerotinia sclerotiorum#684895HAL (France)
• A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis#1454668ClinicalTrials.gov
• Evaluación de bioproductos provenientes de desechos agropecuarios y especies vegetales antifúngicas sobre parámetros productivos y sanitarios en cultivos de frutillas#339615Biblioteca Virtual UNL
• Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)#1453451ClinicalTrials.gov
• An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot#884810ClinicalTrials.gov
• The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis#1173953ClinicalTrials.gov
• A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX#847688ClinicalTrials.gov
• A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS#1353092ClinicalTrials.gov
• A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone#845784ClinicalTrials.gov
• TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.#1445318ClinicalTrials.gov
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children#1438392ClinicalTrials.gov
• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides#830297ClinicalTrials.gov
• An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine#1293618ClinicalTrials.gov
• A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients#892401ClinicalTrials.gov